ResMed, Inc. (RMD)
256.26
-0.80
(-0.31%)
USD |
NYSE |
Feb 27, 16:00
256.00
-0.26
(-0.10%)
Pre-Market: 06:13
ResMed Research and Development Expense (Annual) : 331.28M for June 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Abbott Laboratories | 2.889B |
| Baxter International, Inc. | 503.00M |
| Stryker Corp. | 1.567B |
| Globus Medical, Inc. | 146.94M |